Your browser doesn't support javascript.
loading
Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders.
Zhang, Lusi; Lizano, Paulo; Xu, Yanxun; Rubin, Leah H; Lee, Adam M; Lencer, Rebekka; Reilly, James L; Keefe, Richard S E; Keedy, Sarah K; Pearlson, Godfrey D; Clementz, Brett A; Keshavan, Matcheri S; Gershon, Elliot S; Tamminga, Carol A; Sweeney, John A; Hill, S Kristian; Bishop, Jeffrey R.
Affiliation
  • Zhang L; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.
  • Lizano P; Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, United States; Department of Psychiatry, Harvard Medical School, Boston, MA, United States; Division of Translational Neuroscience, Beth Israel Deaconess Medical Center, Boston, MA, United States.
  • Xu Y; Department of Applied Mathematics and Statistics, Johns Hopkins University, Baltimore, MD, United States.
  • Rubin LH; Department of Neurology, Psychiatry, and Epidemiology, Johns Hopkins University, Baltimore, MD, United States.
  • Lee AM; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States.
  • Lencer R; Institute for Translational Psychiatry, University of Münster, Münster, Germany; Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
  • Reilly JL; Department of Psychiatry and Behavioral Sciences, Northwestern University, Chicago, IL, United States.
  • Keefe RSE; Departments of Psychiatry, Neuroscience, and Psychology, Duke University, Durham, NC, United States.
  • Keedy SK; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, United States.
  • Pearlson GD; Departments of Psychiatry and Neurobiology, School of Medicine, Yale University, New Haven, CT, United States.
  • Clementz BA; Department of Psychology and Neuroscience, University of Georgia, Athens, GA, United States.
  • Keshavan MS; Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, MA, United States; Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
  • Gershon ES; Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, United States.
  • Tamminga CA; Department of Psychiatry, University of Texas Southwestern Medical Center Dallas, TX, United States.
  • Sweeney JA; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, Cincinnati, OH, United States.
  • Hill SK; Department of Psychology, Rosalind Franklin University of Medicine and Science, North Chicago, IL, United States.
  • Bishop JR; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN, United States; Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, Minneapolis, MN, United States. Electronic address: jrbishop@umn.edu.
Schizophr Res ; 255: 69-78, 2023 05.
Article in En | MEDLINE | ID: mdl-36965362
ABSTRACT
Elevated markers of peripheral inflammation are common in psychosis spectrum disorders and have been associated with brain anatomy, pathology, and physiology as well as clinical outcomes. Preliminary evidence suggests a link between inflammatory cytokines and C-reactive protein (CRP) with generalized cognitive impairments in a subgroup of individuals with psychosis. Whether these patients with elevated peripheral inflammation demonstrate deficits in specific cognitive domains remains unclear. To examine this, seventeen neuropsychological and sensorimotor tasks and thirteen peripheral inflammatory and microvascular markers were quantified in a subset of B-SNIP consortium participants (129 psychosis, 55 healthy controls). Principal component analysis was conducted across the inflammatory markers, resulting in five inflammation factors. Three discrete latent cognitive domains (Visual Sensorimotor, General Cognitive Ability, and Inhibitory Behavioral Control) were characterized based on the neurobehavioral battery and examined in association with inflammation factors. Hierarchical clustering analysis identified cognition-sensitive high/low inflammation subgroups. Among persons with psychotic disorders but not healthy controls, higher inflammation scores had significant associations with impairments of Inhibitory Control (R2 = 0.100, p-value = 2.69e-4, q-value = 0.004) and suggestive associations with Visual Sensorimotor function (R2 = 0.039, p-value = 0.024, q-value = 0.180), but not with General Cognitive Ability (R2 = 0.015, p-value = 0.162). Greater deficits in Inhibitory Control were observed in the high inflammation patient subgroup, which represented 30.2 % of persons with psychotic disorders, as compared to the low inflammation psychosis subgroup. These findings indicate that inflammation dysregulation may differentially impact specific neurobehavioral domains across psychotic disorders, particularly performance on tasks requiring ongoing behavioral monitoring and control.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Bipolar Disorder Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Schizophr Res Journal subject: PSIQUIATRIA Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotic Disorders / Schizophrenia / Bipolar Disorder Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Schizophr Res Journal subject: PSIQUIATRIA Year: 2023 Document type: Article Affiliation country: United States